Airway hyperresponsiveness (AHR) associated with hightened airway resistance and inflammation is an asthmatic characteristic feature. Although the importance of AHR in the pathogenesis of asthma has been suggested by its relevance to the severity of this disease, the pathophysiologic alterations leading to the hyperresponsiveness are still unclear. It has been demonstrated that smooth muscle responsiveness to contractile agonists was significantly increased in bronchial preparations from repeatedly antigen challenged rats. 1) Smooth muscle contraction is mainly regulated by an increase in cytosolic Ca 2ϩ concentration in myocytes. Recently, additional mechanism, termed Ca 2ϩ sensitization, has also been suggested to be involved in the agonist-induced smooth muscle contraction. It has been demonstrated that agonist stimulation increases myofilament Ca 2ϩ sensitivity in permeabilized smooth muscles of the rat coronary artery, 2) guinea pig vas deferens, 3) canine trachea, 4) and rat bronchus. 5) Although the detailed mechanism is not fully cleared, an involvement of RhoA, a monomeric GTP-binding protein, in agonist-induced Ca 2ϩ sensitization has been suggested by many investigators. 6) Previously, we demonstrated that the Ca 2ϩ sensitization of the bronchial smooth muscle (BSM) contraction was markedly augmented concomitantly with an increased expression of RhoA protein in the AHR rats and mice. 7,8) Moreover, an augmented RhoA-mediated Ca 2ϩ sensitization of smooth muscle contraction has been reported in experimental animal models of diseases. 9,10) It is thus possible that RhoA-mediated signaling is a crucial key for understanding the abnormal contraction of diseased smooth muscles. Recent studies revealed that the RhoA upregulation is triggered by interleukin (IL)-13 and tumor necrosis factor (TNF)-a, both of which are known as major mediators for development of AHR, via activation of signal transducers and activators of transcription (STAT6) and nuclear factor (NF)-kB in human BSM cells (hBSMCs). 7,11) Glucocorticoids are by far the most effective anti-inflammatory treatment for bronchial asthma and have now become the first-line therapy in all patients with persistent asthma. The predominant effect of glucocorticoids such as prednisolone and beclomethasone is to switch off multiple inflammatory genes that have been activated during the inflammatory process. They have additional effects such as the synthesis of anti-inflammatory proteins and post-genomic effects. Recent studies have also demonstrated that glucocorticoids may affect diverse functions via glucocorticoid receptor (GR), such as an increase in b 2 receptor expression in airway smooth muscle cells, 12) decreases in chemokines and cytokines secretion in airway epithelial cells 13,14) and so on. One mechanism by which GR influences gene expression is by direct physical association with other transcription factor, such as STAT6 and NF-kB to modulate their function. 15,16) On the other hand, clinical studies also revealed that glucocorticoids could red...